Bethesda, MD, United States of America

James Halpern Doroshow

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.6

ph-index = 1


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of James Halpern Doroshow

Introduction

James Halpern Doroshow is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents. With a total of 3 patents, his work focuses on innovative solutions for cancer and inflammatory diseases.

Latest Patents

Doroshow's latest patents include groundbreaking research on iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases. These patents disclose novel iodonium analogs that exhibit anticancer and anti-inflammatory activity. His work in this area has the potential to lead to new treatment options for patients suffering from these conditions.

Career Highlights

Throughout his career, Doroshow has worked with esteemed organizations such as Starks Associates Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute to significant advancements in medical research and innovation.

Collaborations

Doroshow has collaborated with several professionals in his field, including Prabhakar Risbood and Jiamo Lu. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in healthcare.

Conclusion

James Halpern Doroshow's contributions to the field of biomedical research through his patents and collaborations highlight his commitment to advancing medical science. His innovative work continues to pave the way for new therapeutic approaches in treating cancer and inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…